Curcumin suppresses human papillomavirus oncoproteins, restores p53, rb, and ptpn13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7

Molecular Carcinogenesis

Volumn 50, Issue 1, 2011, Pages 47-57

  Maher, Diane M ^a   Bell, Maria C ^a,b   O'Donnell, Emmylu A ^a   Gupta, Brij K ^a,b   Jaggi, Meena ^a,b   Chauhan, Subhash C ^a,b  

^a SANFORD RESEARCH   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Benzo a pyrene (BaP); Cell motility; Cervical cancer; Curcumin; HPV E6 E7; P53; PTPN13; Rb

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; CURCUMIN; HUMAN PAPILLOMAVIRUS ONCOPROTEIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 13; ONCOPROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; TOBACCO SMOKE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL MOTILITY; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 16 E7; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SMOKING; UPREGULATION; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZO(A)PYRENE; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CURCUMIN; FEMALE; FLOW CYTOMETRY; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 13; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; NICOTIANA TABACUM;

EID: 78650184036     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20695     Document Type: Article

References (44)

1. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer-Burden and assessment of causality. J Natl Cancer Inst Monogr 2003: 3-13.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156.
3. Reid J. Women's knowledge of Pap smears, risk factors for cervical cancer, and cervical cancer. J Obstet Gynecol Neonatal Nurs 2001; 30: 299-305.
4. Prevention CfDCa. Genital HPV infection fact sheet. Rockville, MD: CDC National Prevention Information Network; 2004.
5. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370: 890-907.
6. Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111: 278-285.
7. Appleby P, Beral V, Berrington de Gonzalez A, et al. Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13, 541 women with carcinoma of the cervix and 23, 017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006; 118: 1481-1495.
8. McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 2005; 14: 1165-1170.
9. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-841.
10. Leman RF, Espey D, Cobb N. Invasive cervical cancer among American Indian women in the Northern Plains, 1994-1998: Incidence, mortality, and missed opportunities. Public Health Rep 2005; 120: 283-287.
11. Bell MC, Schmidt-Grimminger D, Patrick S, Ryschon T, Linz L, Chauhan SC. There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains. Gynecol Oncol 2007; 107: 236-241.
12. Cigarette smoking among adults-United States, 2006. MMWR Morb Mortal Wkly Rep 2007; 56: 1157-1161.
13. McCann MF, Irwin DE, Walton LA, Hulka BS, Morton JL, Axelrad CM. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev 1992; 1: 125-129.
14. Melikian AA, Sun P, Prokopczyk B, et al. Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer Lett 1999; 146: 127-134.
15. Ogunmodede F, Yale SH, Krawisz B, Tyler GC, Evans AC. Human papillomavirus infections in primary care. Clin Med Res 2007; 5: 210-217.
16. Albrechtsen S, Rasmussen S, Thoresen S, Irgens LM, Iversen OE. Pregnancy outcome in women before and after cervical conisation: Population based cohort study. Br Med J 2008; 337: a1343.
17. Arbyn M, Kyrgiou M, Simoens C, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: Meta-analysis. Br Med J 2008; 337: a1284.
18. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": From kitchen to clinic. Biochem Pharmacol 2008; 75: 787-809.
19. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: An "old-age" disease with an "age-old" solution. Cancer Lett 2008; 267: 133-164.
20. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 2006; 69: 195-206.
21. Hong RL, Spohn WH, Hung MC. Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. Clin Cancer Res 1999; 5: 1884-1891.
22. Shao ZM, Shen ZZ, Liu CH, et al. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 2002; 98: 234-240.
23. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: A short review. Life Sci 2006; 78: 2081-2087.
24. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001; 21: 2895-2900.
25. Chauhan SC, Vannatta K, Ebeling MC, et al. Expression and functions of transmembrane mucin MUC13 in ovarian cancer. Cancer Res 2009; 69: 765-774.
26. Lambert PF, Ozbun MA, Collins A, Holmgren S, Lee D, Nakahara T. Using an immortalized cell line to study the HPV life cycle in organotypic "raft" cultures. Methods Mol Med 2005; 119: 141-155.
27. Spanos WC, El-Deiry M, Lee JH. Cidofovir incorporation into human keratinocytes with episomal HPV 16 results in nonselective cytotoxicity. Ann Otol Rhinol Laryngol 2005; 114: 840-846.
28. Carlson MW, Iyer VR, Marcotte EM. Quantitative gene expression assessment identifies appropriate cell line models for individual cervical cancer pathways. BMC Genomics 2007; 8: 117.
29. zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350.
30. Spanos WC, Hoover A, Harris GF, et al. The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth. J Virol 2008; 82: 2493-2500.
31. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
32. Divya CS, Pillai MR. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol Carcinog 2006; 45: 320-332.
33. Prusty BK, Das BC. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 2005; 113: 951-960.
34. Singh M, Singh N. Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells. Mol Cell Biochem 2009; 325: 107-119.
35. Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins. Cancer Sci 2007; 98: 1505-1511.
36. Calleja-Macias IE, Kalantari M, Bernard HU. Cholinergic signaling through nicotinic acetylcholine receptors stimulates the proliferation of cervical cancer cells: An explanation for the molecular role of tobacco smoking in cervical carcinogenesis? Int J Cancer 2009; 124: 1090-1096.
37. Alam S, Conway MJ, Chen HS, Meyers C. The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J Virol 2008; 82: 1053-1058.
38. Shishodia S, Potdar P, Gairola CG, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: Correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 2003; 24: 1269-1279.
39. Cheng SE, Luo SF, Jou MJ, et al. Cigarette smoke extract induces cytosolic phospholipase A(2) expression via NADPH oxidase, MAPKs, AP-1, and NF-kappaB in human tracheal smooth muscle cells. Free Radic Biol Med 2009; 46: 948-960.
40. Fuchs SY, Ronai Z. Elevated binding to URE/PEBP2 during the late stages of NNK and benzo[a]pyrene-induced carcinogenesis in A/J mice. Cancer Lett 1996; 102: 101-106.
41. Cooper SJ, Bowden GT. Ultraviolet B regulation of transcription factor families: Roles of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis. Curr Cancer Drug Targets 2007; 7: 325-334.
42. Mortaz E, Kraneveld AD, Smit JJ, et al. Effect of cigarette smoke extract on dendritic cells and their impact on T-cell proliferation. PLoS ONE 2009; 4: e4946.
43. ClinicalTrials, gov. p U.S. National Institutes of Health Database of government and private clinical trials. 2009.
44. Yallapu MM, Maher DM, Sundram V, Bell MC, Jaggi M, Chauhan SC. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res 2010; 3: 11.